ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ELOX Eloxx Pharmaceuticals Inc

3.82
0.00 (0.00%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Eloxx Pharmaceuticals Inc ELOX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 3.82 09:00:00
개장가 저가 고가 종가 전일 종가
3.82 3.82
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202420:30GLOBEEloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program..
02/04/202405:02EDGAR2Form NT 10-K - Notification of inability to timely file Form..
30/03/202405:11EDGAR2Form 8-K - Current report
22/03/202403:20EDGAR2Form 25-NSE - Notification filed by national security..
15/03/202405:30EDGAR2Form 8-K - Current report
14/03/202400:42GLOBEAlmirall and Eloxx Pharmaceuticals Enter into Exclusive..
27/01/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202411:44EDGAR2Form S-3 - Registration statement under Securities Act of..
25/01/202407:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/01/202407:10EDGAR2Form 8-K - Current report
29/12/202306:11EDGAR2Form 8-K - Current report
14/11/202306:15GLOBEEloxx Pharmaceuticals Reports Third Quarter 2023 Financial..
17/10/202306:26EDGAR2Form 8-K - Current report
09/10/202321:00GLOBEEloxx Pharmaceuticals Reports Additional Confirmation that..
21/09/202305:05EDGAR2Form 8-K - Current report
21/09/202302:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/09/202321:00GLOBEEloxx Pharmaceuticals Announces $2 Million Registered Direct..
18/09/202321:05EDGAR2Form 8-K - Current report
18/09/202320:00GLOBEEloxx Pharmaceuticals Reports Independent Confirmation of..
16/09/202306:15EDGAR2Form 8-K - Current report
07/09/202323:14EDGAR2Form 8-K - Current report
07/09/202322:00GLOBEEloxx Pharmaceuticals Provides Program Updates on ELX-02 and..
30/08/202305:32EDGAR2Form 8-K - Current report
22/08/202305:50EDGAR2Form 8-K - Current report
15/08/202300:56EDGAR2Form 8-K - Current report
14/08/202321:30GLOBEEloxx Pharmaceuticals Reports Second Quarter 2023 Financial..
14/08/202321:00GLOBEEloxx Pharmaceuticals Reports Drug Response in All Patients..
12/08/202305:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/08/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:01EDGAR2Form 8-K - Current report
03/08/202322:26GLOBEEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
13/07/202321:43EDGAR2Form 8-K - Current report
10/07/202322:00GLOBEEloxx Pharmaceuticals Announces Publication Demonstrating..
28/06/202322:00GLOBEEloxx Pharmaceuticals Key Opinion Leader Event Highlights..
22/06/202302:30GLOBEEloxx Pharmaceuticals to Host Investor and Analyst Call on..
21/06/202322:00GLOBEEloxx Pharmaceuticals Highlights Recent Alport Syndrome..
15/06/202305:53GLOBEEloxx Pharmaceuticals Announces Final Data Assessment from..
06/06/202321:30GLOBEEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
01/06/202322:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
24/05/202321:00GLOBEEloxx Pharmaceuticals Intends to Advance ELX-02 into Pivotal..
16/05/202305:30GLOBEEloxx Pharmaceuticals Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock